Biotech Series A Investors & VC Firms
1596 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.
Yuanta Investment
SeoulSeed–Late Stage$1M – $15M
BrightEdge
AtlantaSeed–Late Stage
1 person
BSK Investment
SeoulSeed–Late Stage
2 people
East Gate Partners
SeoulSeed–Series A
2 people
Global Venture Capital, Inc.
TokyoSeed–Series A
2 people
Hanne Capital
ShanghaiSeed–Late Stage
2 people
Magellan Technology Investment
SeoulSeed–Series A
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
New Technology Ventures
Newton Lower FallsSeed–Series A
2 people
Omron Ventures
KyotoSeed–Growth
2 people
Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd.
ShenzhenSeed–Series B
2 people
Tohoku Innovation Capital Corporation
MiyagiSeed–Series A
2 people
Vesalius Ventures
HoustonSeed–Series B
2 people
Wild Basin Investments
TexasSeed–Growth
2 people
Yonjin Venture LLC
CambridgeSeed–Series B
2 people
Alexandria
PasadenaSeed–Late Stage
1 person
Birk Venture
OsloSeed–Series B
1 person
Ippon
GenevaSeries A–Growth
1 person
Shea Ventures, LLC
WalnutSeed–Series A
1 person
ARAX Capital Partners GmbH
ViennaSeed–Series A$2.2M
1 person
Astellas Venture Management
ChicagoSeed–Growth
1 person
Augere Venture
KrakówSeed–Late Stage
1 person
Bio Sight Capital, Inc.
OsakaSeed–Series A
1 person
CDTM Venture Fund
MunichPre-Seed–Series A
1 person
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)
Data sourced from public filings and firms' own websites — see our methodology.


